- Home
- GLDD vs AQST Comparison
GLDD vs AQST Comparison
Compare GLDD & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDD
- AQST
- Stock Information
- Founded
- GLDD 1890
- AQST 2004
- Country
- GLDD United States
- AQST United States
- Employees
- GLDD N/A
- AQST N/A
- Industry
- GLDD Military/Government/Technical
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- GLDD Industrials
- AQST Health Care
- Exchange
- GLDD Nasdaq
- AQST Nasdaq
- Market Cap
- GLDD 813.2M
- AQST 809.3M
- IPO Year
- GLDD 2006
- AQST 2018
- Fundamental
- Price
- GLDD $12.29
- AQST $6.14
- Analyst Decision
- GLDD
- AQST Strong Buy
- Analyst Count
- GLDD 0
- AQST 6
- Target Price
- GLDD N/A
- AQST $10.33
- AVG Volume (30 Days)
- GLDD 444.3K
- AQST 2.9M
- Earning Date
- GLDD 11-04-2025
- AQST 11-05-2025
- Dividend Yield
- GLDD N/A
- AQST N/A
- EPS Growth
- GLDD 36.27
- AQST N/A
- EPS
- GLDD 1.19
- AQST N/A
- Revenue
- GLDD $834,599,000.00
- AQST $43,397,000.00
- Revenue This Year
- GLDD $13.73
- AQST N/A
- Revenue Next Year
- GLDD $3.56
- AQST $51.39
- P/E Ratio
- GLDD $10.24
- AQST N/A
- Revenue Growth
- GLDD 12.53
- AQST N/A
- 52 Week Low
- GLDD $7.51
- AQST $2.12
- 52 Week High
- GLDD $12.93
- AQST $7.55
- Technical
- Relative Strength Index (RSI)
- GLDD 61.20
- AQST 45.82
- Support Level
- GLDD $11.14
- AQST $5.84
- Resistance Level
- GLDD $12.93
- AQST $6.93
- Average True Range (ATR)
- GLDD 0.43
- AQST 0.40
- MACD
- GLDD 0.18
- AQST -0.17
- Stochastic Oscillator
- GLDD 71.63
- AQST 16.67
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.